PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT07615712
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Observational (Non-Interventional) Registry — OTHER
    This is an observational (non-interventional) registry

Study Details

This is a 16-week prospective, single-arm cohort, study of patients initiating advanced therapy for the treatment of moderate-to-severe plaque PSO. Eligible patients must be willing to be seen in-person by their treating physician for a Baseline visit (with first dose of the advanced therapy occurring within 14 days), and at 2 (+/- 5 days), 4 (+/- 5 days), and 16 weeks (+14 days) calculated based on date of first dose of the advanced therapy and must provide informed consent prior to enrolling in the study or completing study-specific questionnaires or procedures. Data will be collected from both subjects and their treating dermatology provider at predetermined scheduled intervals (Baseline, Week 2, Week 4, and Week 16) using a structured and standardized data collection tool.

Key Dates

Start date
Apr 30, 2025
Status verified
May 2026
Primary completion
Dec 31, 2035
Completion
Dec 31, 2035

Study Design

Enrollment
2,500 participants (estimated)

Primary Outcome Measure

Creation of a cohort of psoriasis subjects [ Time Frame: Baseline (Day 0), Week 2, 4 and 16 weeks after initiation of advanced therapy ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451
Cathy Cheney
[email protected]
508-555-1212
[email protected]
508-555-1212

Find similar trials in Waltham, MA

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
CorEvitas, LLC· Waltham, MA

Related Studies